Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1868.62 (Glytoucan)

Id:e0ad392f-ee94-5621-8fb3-5a2e0d9ba9b2

Glytoucan:G72001GR

Results found

Linked to

	Label	Description
	1868.62 has canonical residue n-glycan core b-d-manp c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G45753KE-GLYCOSEQ00058328 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000092 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G72001GR-GLYCOSEQ00186277 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G68955EJ-GLYCOSEQ00156931 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G68955EJ-GLYCOSEQ00156936 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G69749VJ-GLYCOSEQ00076335 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has canonical residue n-glycan core b-d-manp c

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G45753KE-GLYCOSEQ00058328 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000092 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G72001GR-GLYCOSEQ00186277 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G68955EJ-GLYCOSEQ00156931 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G68955EJ-GLYCOSEQ00156936 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.62 has glycosequence GLYGEN.GLYCOSEQUENCE:G69749VJ-GLYCOSEQ00076335 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.